Lilly’s Mounjaro Diabetes Approval Is First Challenge To Novo’s GLP-1 Franchise

Tirzepatide Showed Superiority To Ozempic In Clinical Trials

 
• By Mandy Jackson
  
Top view of diabetes tester set with athlete's equipment; measuring tape, green dumbbell and fruit
Beyond diabetes, Lilly is developing tirzepatide for obesity, NASH and heart failure • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip